SCHEMBL201173

SCHEMBL201173

N#Cc1ccc(-c2csc(COc3ccc(F)c(C(N)=O)c3F)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.43
POLB P06746 1/20 0.43
SCN9A Q15858 1/20 0.42
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
PPARD Q03181 4/20 0.41
VCP P55072 1/20 0.40
MEN1 O00255 4/20 0.39
GAA P10253 3/20 0.39
KDM4E B2RXH2 3/20 0.39
PPARA Q07869 2/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705816 0.89 L3MBTL1 (0.53) L3MBTL1POLBRAB9ANPC1CASP3
SCHEMBL204423 0.89 L3MBTL1 (0.45) L3MBTL1POLBRAB9ANPC1CASP3
SCHEMBL2704589 0.88 PPARD (0.52) L3MBTL1POLBRAB9ANPC1CASP3
SCHEMBL2707296 0.87 RAB9A (0.54) L3MBTL1POLBRAB9ANPC1CASP3
SCHEMBL201521 0.86 PPARD (0.49) L3MBTL1POLBSCN9ARAB9ANPC1
SCHEMBL10220910 0.85 L3MBTL1 (0.41) L3MBTL1POLBSCN9ARAB9ANPC1
SCHEMBL2707366 0.85 L3MBTL1 (0.55) L3MBTL1POLBSCN9ARAB9ANPC1
SCHEMBL19471075 0.85 L3MBTL1 (0.42) L3MBTL1POLBRAB9ANPC1CASP3
SCHEMBL203280 0.85 L3MBTL1 (0.59) L3MBTL1POLBRAB9ANPC1CASP3
SCHEMBL2706162 0.83 HDAC3 (0.48) L3MBTL1POLBSCN9ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
WO-2007107758-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072520-A2 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 L3MBTL1 703/4885POLB 364/4885SCN9A 1697/4885
US-20150191420-A1 ANTIBACTERIAL AGENTS ALK, ARG1, ROS1 L3MBTL1 377/4885POLB 435/4885SCN9A 2389/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 L3MBTL1 703/4885POLB 364/4885SCN9A 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.